Orasis expands access to presbyopia treatment with Qlosi starter packs

Orasis Pharmaceuticals has introduced Qlosi (pilocarpine hydrochloride ophthalmic solution) 0.4% Starter Packs, aiming to expand access to its presbyopia treatment and enhance hands-on experience for eye care professionals, according to a press release. Each Starter Pack contains 10 single-use vials, which is enough for 5 days of twice-daily treatment, along...